U.S. National Institutes of Health National Cancer Institute www.cancer.gov
U.S. National Institutes of Health nih.gov
NCI NewsCenter
NCI Budget Data
Visuals Online
NCI Fact Sheets
Understanding Cancer SeriesBenchmarks articles from the selected year appear below. To view articles from previous years, use the links to the left, and select the year you wish to see.
July 25, 2001
Objectives
I. Assess the therapeutic efficacy and toxicity of the recombinant immunotoxin LMB-2, an anti-Tac murine monoclonal antibody fragment conjugated to a truncated portion of Pseudomonas exotoxin, in patients with Tac-expressing leukemias and lymphomas.